Although molecular genetic studies of rhabdoid tumors typically reveal the biallelic inactivation of the SMARCB1 gene, other tumor types (schwannomas, meningiomas) may also show deletions or mutations of the SMARCB1 gene that lead to a loss of INI1 protein expression. This evidence concerns the gene SMARCB1 and meningioma.